Johnson & Johnson tops fourth-quarter expectations but signals sales to slow this year

Health, Fitness & Food

Johnson & Johnson reported quarterly earnings and revenue that beat analysts’ expectations and gave its financial forecast for this year.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.97, adjusted, vs. $1.95 expected
  • Revenue: $20.4 billion vs. $20.2 billion expected

J&J forecast 2019 earnings of between $8.50 and $8.65 per share and revenue in the range of $80.4 billion to $81.2 billion. Analysts previously said they expected earnings $8.60 per share and $82.69 billion in revenue, according to Refinitiv.

J&J’s usually steady stock has been under pressure recently. A December report from Reuters said J&J knew for decades its talc baby powder contained asbestos. The company has repeatedly denied any wrongdoing and stands behind its namesake baby powder.

Since Reuters published its report, J&J shares have fallen by about 9.5 percent. Analysts called the selloff overdone, saying any litigation risk would cost less than the billions of dollars J&J lost in market cap.

Products You May Like

Articles You May Like

Trump administration proposes easing privacy rules for addiction history
What to know about HER2-negative breast cancer
Juul’s momentum slips as NJOY woos customers with dollar e-cigarettes
Fluoridated water: Maternal exposure may affect children’s IQs
Inflammation in type 2 diabetes: Study overturns previous notions

Leave a Reply

Your email address will not be published. Required fields are marked *